Tech Company Financing Transactions
VeriSIM Life Funding Round
VeriSIM Life closed a $5.2 million Seed funding round on 8/16/2019. Investors included OCA Ventures, Serra Ventures and Intel Capital.
Transaction Overview
Company Name
Announced On
8/16/2019
Transaction Type
Venture Equity
Amount
$5,200,000
Round
Seed
Investors
OCA Ventures (Lead Investor)
Serra Ventures (Lead Investor)
Proceeds Purpose
With this new funding, VSL will be able to optimize its models through expanded academic partnerships, grow a team to include world-class talent in the engineering and operations space, and engage with greater agency when working with larger pharma institutions.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
505 Montgomery St.
San Francisco, CA 94111
USA
San Francisco, CA 94111
USA
Phone
Undisclosed
Website
Email Address
Overview
VeriSIM Life is building AI enabled biosimulation models. VeriSIM will tackle one of the biggest obstacles of drug development: animal testing for drug development. Animal testing is slow, ethically questionable, and doesn't act as much of a filter: 92% of all drug candidates that pass this preclinical testing never make it to market.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jo Varshney
VP - Engineering
Hal Eisen
Browse more venture capital transactions:
Prev: 8/16/2019: Fitz Frames venture capital transaction
Next: 8/16/2019: Vuori venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. All VC database entries on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs